As of Nov 20
| -0.03 / -0.01%|
The 26 analysts offering 12-month price forecasts for Biogen Inc have a median target of 300.00, with a high estimate of 370.00 and a low estimate of 235.00. The median estimate represents a +5.12% increase from the last price of 285.40.
The current consensus among 31 polled investment analysts is to Hold stock in Biogen Inc. This rating has held steady since November, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.